Skip to content

Checked

State dataHealth

Nateglinide

Published by State of Virginia 路 Updated 06/12/2026

Last updated
06/12/2026
First published 11/27/2025
Update frequency
Not listed
Formats
Web only
Coverage
Virginia
Statewide

About this dataset

Nateglinide is a prescription medication used to help manage type 2 diabetes by lowering blood sugar levels. It works as a glinide that stimulates insulin release from the pancreas. Available as oral tablets in 60 mg and 120 mg strengths, it's manufactured by Rising Pharma Holdings, Inc. under application ANDA205544. This information was generated using AI and is provided for informational and research purposes only. --- ### 馃敆 Related Datasets - [Nateglinide](https://odgavaprod.ogopendata.com//dataset/44864515-7ae2-489e-9786-8ce33c444ad8) - *HealthData.Gov* - [Nateglinide](https://odgavaprod.ogopendata.com//dataset/72e546ed-f093-4068-81df-9b6d79379e5c) - *HealthData.Gov* ---

Files and access

Links open the official government source

Links open outside websites we do not control.

Details

Platform
CKAN open data portal
Keywords
drug-safety, fda, harvested, health-care, pharmaceuticals, prescription-drugs

More from State of Virginia

All

Similar data from other publishers

Frequently asked questions

Who publishes Nateglinide?
State of Virginia publishes this dataset on Virginia Open Data Portal.
How often is it updated?
The publisher does not list a schedule. The last update was on 06/12/2026.
How do I download it?
Use the official source link above to view or request the data.

Source: Virginia Open Data Portal 路 Last updated 10/21/2026 路 Listing only; the data stays with the publisher